Author

M. Chesnokov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Yousif· 1 shared G. Mehta· 1 shared I. Chefetz Menaker· 1 shared I. Khan· 1 shared J. Ezel· 1 shared L. Hong· 1 shared R. J. Buckanovich· 1 shared Y. Park· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Yousif

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivSep 16, 2019

The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma

M. Chesnokov, I. Khan, Y. Park…·I. Chefetz Menaker

This study investigates MEK1/2 pathway activity in high-grade serous ovarian carcinoma and shows that its inhibition reduces tumor growth but promotes stem-like properties, suggesting potential resistance mechanisms.

DOI 10.3390/cancers13061369

humanproteomics

𝕏 PostBluesky